Company Core Values

Company Core Values

Service Categories

Service Categories

Core Advantages

Core Advantages

Scroll Down
About Us

Boruiheng Pharmaceutical

Leading precision drug analysis and empowering global pharmaceutical R&D.

Boruiheng Pharmaceutical Technology Co., Ltd. is deeply rooted in Biolake, which is renowned as China's biomedical innovation hub and located in Wuhan East Lake High-tech Development Zone. Since our establishment in 2012, we have remained dedicated to the fields of pharmacokinetic studies, bioequivalence testing, analysis and detection of large/small molecule drugs, committed to establish a one-stop bioanalytical solution that covers the entire “preclinical to clinical studies” chain.
See more

8619913181561 Service Hotline

1600 ㎡

High-standard laboratory

200

Stable strategic partnership

2000 +

Drug Research Project

500 +

Small-molecule drug approach

30 +

Biological macromolecular drug approach

Service Scope

See more

Preclinical Bioanalysis

Preclinical Bioanalysis

Preclinical Pharmacokinetic Studies (PK) Preclinical Pharmacokinetics (and Toxicokinetics) Studies (TK) Drug-Drug Interaction (DDI) Assessment More services

Clinical Bioanalysis

Clinical Bioanalysis

Pharmacokinetic Study (PK) Pharmacodynamic Studies (PD) Formulation Consistency Evaluation and Human Bioequivalence (BE) Studies More services

Other Services

Other Services

Genotoxic impurities Therapeutic Drug Monitoring (TDM) Metal Element Detection More services

Featured Platform

See more

Service Advantages

See more

Technical barriers

More than 500 analytical methods are already available (including those for endogenous substances, unstable metabolites, low-response compounds, and more), covering all categories of pharmaceuticals.

High configuration undertaking

Annual testing throughput can reach up to 2 million, eliminating the need for projects to wait in a scheduling queue.

Efficient delivery

A digital management system combined with comprehensive operational SOPs accelerates project delivery.

Quality assurance

Standardized processes + intelligent scheduling mechanisms + end-to-end quality control ensure high-quality delivery for every project.

Analysis of Key and Difficult Compounds

See more

Calcitriol

Endogenous, low sensitivity

Insulin

Endogenous peptide

Thrombin IIa Factor

Endogenous and unstable

Eldecalcitol

Low sensitivity, difficult to ionize

Ursodeoxycholic acid

Endogenous, Multi-Metabolite Detection

Thrombin Xa Factor

Endogenous and unstable

Fecal fatty acids

Low sensitivity, unstable

Glucose

Endogenous

Gastric lipase

Unstable

Succinylated Gelatin

Enzymatic method, low sensitivity

Total Estrone

Low sensitivity, enzymatic method

Pancreatic lipase

Unstable

Estradiol and dydrogesterone

Endogenous, low sensitivity

Risedronic Acid

Derivatization Monitoring

Indacaterol Glycopyrronium Bicarbonate

Low sensitivity

HRSX-B-2315

ADC, Multi-Component Detection

Semaglutide

Multiple-dose testing

Levodopa and Carbidopa

Endogenous, Chiral Separation

Levamlodipine Besylate

Chiral Separation

Drospirenone and Ethinyl Estradiol Tablets

Endogenous, low sensitivity

Dibutylphthalide (hydroxypropyl cyclodextrin)

Multi-component detection

Tirzepatide

Popular Peptide

Eicosapentaenoic acid

Endogenous, Multi-Metabolite Detection

Insulin glargine

Multi-metabolite detection, low sensitivity

Insulin aspart

Low sensitivity

Budesonide Formoterol Inhalation Powder Aerosol

Multi-metabolite detection, low sensitivity

Compound Betamethasone Injection

Multi-metabolite detection, unstable

Testosterone Undecanoate Hard Capsules

Endogenous, low-sensitivity, multi-component detection

Itraconazole & Hydroxyitraconazole

Multi-metabolite profiling, liposomes

Icodextrin

Enzymatic hydrolysis, low sensitivity, multi-metabolite detection

Blogs

See more

Double Celebration Shines Bright | Berriheng Warmly Reunites, Embarking Together on a New Journey of Growth—Employee Recognition Ceremony & Birthday Party Held as Scheduled

05-30

2025

Double Celebration Shines Bright | Berriheng Warmly Reunites, Embarking Together on a New Journey of Growth—Employee Recognition Ceremony & Birthday Party Held as Scheduled

At the event's outset, the company proudly honored its top-performing employees of the quarter by presenting them with certificates of recognition and bespoke awards, celebrating their unwavering dedication to excellence in the biopharmaceutical testing field. Whether it was the technical experts who meticulously manage experimental data or the skilled managers who seamlessly coordinate projects, each individual exemplified the company’s core value of "Professionalism Drives Value" through their relentless pursuit of precision and innovation. Their exemplary efforts have become the benchmark for the entire team to strive toward. The room erupted in enthusiastic applause—both a heartfelt acknowledgment of these role models and a powerful testament to Berriheng employees' collective determination to continuously elevate themselves to meet the highest standards.

Read More

Boruiheng Joins Donghu Biopharmaceutical Association: Partnering with Optics Valley’s "Pharmaceutical Valley" to Jointly Build an Innovative Ecosystem

05-29

2025

Boruiheng Joins Donghu Biopharmaceutical Association: Partnering with Optics Valley’s "Pharmaceutical Valley" to Jointly Build an Innovative Ecosystem

In February 2025, Wuhan Buruiheng Pharmaceutical Technology Co., Ltd. officially became a member unit of the Wuhan East Lake National Independent Innovation Demonstration Zone Biomedical Industry Association, marking the company's deep integration into the innovation ecosystem of Optics Valley Bio-City and launching a new journey of collaborative industry-academia-research development.

Read More

Good News | Wuhan Beruiheng BSL-2 Laboratory Successfully Registered!

10-08

2023

Good News | Wuhan Beruiheng BSL-2 Laboratory Successfully Registered!

Recently, Wuhan Buruiheng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Wuhan Buruiheng) successfully completed the on-site audit of its laboratory facilities and operational system conducted by an expert team from the Wuhan Municipal Health Commission, smoothly obtaining Level 2 Biosafety (BSL-2, also known as P2) laboratory registration under.Record number: E Health Safety BSL-2 [2023] 01-14-021

Read More

Great news! Fast-rising Beriheng has been named a 2022 "Optics Valley Gazelle" company!

12-08

2022

Great news! Fast-rising Beriheng has been named a 2022 "Optics Valley Gazelle" company!

On December 5, Wuhan Boreiheng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Boreiheng") received the prestigious "Optics Valley Gazelle" Corporate Plaque for 2022, awarded by the Wuhan East Lake High-tech Development Zone. Recognized as a high-growth enterprise with strong technological capabilities, significant growth potential, and mastery of critical core technologies, Boreiheng has been proudly named among China's Optics Valley Gazelle companies.

Read More

Good News | Wuhan Beriheng Pharmaceutical Technology Co., Ltd. has been recognized as a member of the seventh batch of "Specialized, Fine, and New" SMEs in Hubei Province!

05-09

2022

Good News | Wuhan Beriheng Pharmaceutical Technology Co., Ltd. has been recognized as a member of the seventh batch of "Specialized, Fine, and New" SMEs in Hubei Province!

On May 8, 2025, the Hubei Provincial Department of Economy and Information Technology officially announced the seventh batch of provincial-level specialized, sophisticated, and innovative (SSM) SMEs. Wuhan Boreiheng Pharmaceutical Technology Co., Ltd. successfully earned the title of "Hubei Provincial SSM Enterprise," thanks to its strong advantages in specialization, precision, and distinctive development within the pharmaceutical technology sector—and after passing rigorous multi-level evaluations! This achievement marks another significant milestone for the company, following its recent recognition as a National High-Tech Enterprise, further solidifying its leadership in innovation capability, market competitiveness, and industry influence.

Read More

Good News | Borei Heng Pharmaceutical Elected as a Member of the CRO Division of the China Association for Pharmaceutical Quality Management

11-12

2021

Good News | Borei Heng Pharmaceutical Elected as a Member of the CRO Division of the China Association for Pharmaceutical Quality Management

On September 14, 2024, the third meeting of the Clinical Trial Contract Research Organization Branch (hereafter referred to as the CRO Branch) of the China Association for Pharmaceutical Quality Management was successfully held in Wuhan. Attendees included Ye Xiaoping, Chairman of Hangzhou Tigermed Co., Ltd. and Chairperson-elect of the CRO Branch; Wu Jie, Chairman of Northway (Beijing) Pharmaceutical Technology Co., Ltd.; along with nearly 60 representatives from 36 member organizations. The meeting was chaired by Wang Wei, Senior Vice President of Northway (Beijing) Pharmaceutical Technology Co., Ltd. and Secretary-General of the CRO Branch.

Read More

Great News | Borei Heng Pharmaceutical Enters the National High-Tech Enterprise Ranking!

05-10

2020

Great News | Borei Heng Pharmaceutical Enters the National High-Tech Enterprise Ranking!

As one of the nation’s highest honors for high-tech enterprises, qualification recognition requires meeting several key criteria simultaneously: the core technology must possess independent intellectual property rights, the products or services must fall within the scope of high-tech fields, the company must have a significant proportion of science and technology professionals, demonstrate robust research and development expenditures, showcase strong innovation capabilities, effectively convert scientific and technological achievements into market value, and meet favorable growth indicators.

Read More

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home